{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T20:24:53Z","timestamp":1776889493943,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T00:00:00Z","timestamp":1595721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T00:00:00Z","timestamp":1595721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Advicenne"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Distal renal tubular acidosis (dRTA), due to impaired acid secretion in the urine, can lead to severe long-term consequences. Standard of care (SoC) oral alkalizers, requiring several daily intakes, are currently used to restore normal plasma bicarbonate levels. A new prolonged-release formulation, ADV7103, has been developed to achieve a sustained effect with an improved dosing scheme.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a multicenter, open-label, non-inferiority trial (<jats:italic>n<\/jats:italic>\u2009=\u200937), patients with dRTA were switched from SoC to ADV7103. Mean plasma bicarbonate values and proportion of responders during steady state therapy with both treatments were compared, as were other blood and urine parameters, as well as acceptability, tolerability, and safety.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>When switching from SoC to ADV7103, the number of daily intakes was reduced from a median of three to twice daily. Mean plasma bicarbonate was increased and non-inferiority of ADV7103 was demonstrated (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, per protocol), as was statistical superiority (<jats:italic>p<\/jats:italic>\u2009=\u20090.0008, intention to treat [ITT]), and the response rate increased from 43 to 90% with ADV7103 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, ITT). Urine calcium\/citrate ratio was reduced below the threshold for risk of lithogenesis with ADV7103 in 56% of previously non-responders with SoC (<jats:italic>p<\/jats:italic>\u2009=\u20090.021, ITT). Palatability was improved (difference [95% CI] of 25 [10.7, 39.2] mm) and gastrointestinal discomfort was reduced (difference [95% CI] of \u2212\u200914.2 [\u2212\u200925.9, \u2212\u20092.6] mm) with ADV7103.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Plasma bicarbonate levels and response rate were significantly higher with ADV7103 than with SoC. Urine calcium\/citrate ratio, palatability, and gastrointestinal safety were significantly improved, supporting the use of ADV7103 as first-line treatment for dRTA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Registered as EudraCT 2013-002988-25 on the 1st July 2013<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00467-020-04693-2","type":"journal-article","created":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T04:45:46Z","timestamp":1595738746000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4207-824X","authenticated-orcid":false,"given":"Aur\u00e9lia","family":"Bertholet-Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Guittet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Manso-Silv\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Castang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Cailliez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Gillion-Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilija","family":"Golubovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Harambat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Knebelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Novo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila","family":"Podracka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwena\u00eblle","family":"Roussey-Kesler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc-Andr\u00e9","family":"Granier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,26]]},"reference":[{"key":"4693_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000478781","volume":"3","author":"F Trepiccione","year":"2017","unstructured":"Trepiccione F, Prosperi F, de la Motte LR et al (2017) New findings on the pathogenesis of distal renal tubular acidosis. Kidney Dis 3:98\u2013105","journal-title":"Kidney Dis"},{"key":"4693_CR2","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1097\/01.ASN.0000023430.92674.E5","volume":"13","author":"SJ Rodriguez","year":"2002","unstructured":"Rodriguez SJ (2002) Renal tubular acidosis: the clinical entity. J Am Soc Nephrol 13:2160\u20132170","journal-title":"J Am Soc Nephrol"},{"key":"4693_CR3","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1093\/ndt\/gfs442","volume":"27","author":"D Batlle","year":"2012","unstructured":"Batlle D, Haque SK (2012) Genetic causes and mechanisms of distal renal tubular acidosis. Nephrol Dial Transplant 27:3691\u20133704","journal-title":"Nephrol Dial Transplant"},{"key":"4693_CR4","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00467-018-3965-8","volume":"33","author":"M Alonso-Varela","year":"2018","unstructured":"Alonso-Varela M, Gil-Pena H, Coto E et al (2018) Distal renal tubular acidosis. Clinical manifestations in patients with different underlying gene mutations. Pediatr Nephrol 33:1523\u20131529","journal-title":"Pediatr Nephrol"},{"key":"4693_CR5","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00431-010-1184-9","volume":"169","author":"T Saito","year":"2010","unstructured":"Saito T, Hayashi D, Shibata S et al (2010) Novel compound heterozygous ATP6V0A4 mutations in an infant with distal renal tubular acidosis. Eur J Pediatr 169:1271\u20131273","journal-title":"Eur J Pediatr"},{"key":"4693_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1159\/000488698","volume":"43","author":"E Park","year":"2018","unstructured":"Park E, Cho MH, Hyun HS et al (2018) Genotype-phenotype analysis in pediatric patients with distal renal tubular acidosis. Kidney Blood Press Res 43:513\u2013521","journal-title":"Kidney Blood Press Res"},{"key":"4693_CR7","first-page":"e3128","volume":"8","author":"A Shahbaz","year":"2018","unstructured":"Shahbaz A, Shahid MF, Saleem HMK et al (2018) Hypokalemic paralysis secondary to renal tubular acidosis revealing underlying Sj\u00f6gren's syndrome. Cureus 8:e3128","journal-title":"Cureus"},{"key":"4693_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/rheumatology\/kei110","volume":"45","author":"F Pessler","year":"2006","unstructured":"Pessler F, Emery H, Dai L et al (2006) The spectrum of renal tubular acidosis in paediatric Sj\u00f6gren syndrome. Rheumatology 45:85\u201391","journal-title":"Rheumatology"},{"key":"4693_CR9","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00296-018-4118-x","volume":"12","author":"A Jain","year":"2018","unstructured":"Jain A, Srinivas BH, Emmanuel D et al (2018) Renal involvement in primary Sjogren's syndrome: a prospective cohort study. Rheumatol Int 12:2251\u20132262","journal-title":"Rheumatol Int"},{"key":"4693_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1146\/annurev.med.52.1.471","volume":"52","author":"D Batlle","year":"2001","unstructured":"Batlle D, Ghanekar H, Jain S, Mitra A (2001) Hereditary distal renal tubular acidosis: new understandings. Annu Rev Med 52:471\u2013484","journal-title":"Annu Rev Med"},{"key":"4693_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/ndt\/gfy409","volume":"34","author":"SC Lopez-Garcia","year":"2019","unstructured":"Lopez-Garcia SC, Emma F, Walsh SB et al (2019) Treatment and long-term outcome in primary distal renal tubular acidosis. Nephrol Dial Transplant 34:981\u2013991","journal-title":"Nephrol Dial Transplant"},{"key":"4693_CR12","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.kint.2016.12.017","volume":"91","author":"V Palazzo","year":"2017","unstructured":"Palazzo V, Provenzano A, Becherucci F et al (2017) The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis. Kidney Int 91:1243\u20131255","journal-title":"Kidney Int"},{"key":"4693_CR13","first-page":"92","volume":"3","author":"JCM Chan","year":"2007","unstructured":"Chan JCM, Santos F (2007) Renal tubular acidosis in childhood. World J Pediatr 3:92\u201397","journal-title":"World J Pediatr"},{"key":"4693_CR14","first-page":"202","volume":"4","author":"M Sharifian","year":"2010","unstructured":"Sharifian M, Esfandiar N, Mazaheri S et al (2010) Distal renal tubular acidosis and its relationship with hearing loss in children: preliminary report. Iran J Kidney Dis 4:202\u2013206","journal-title":"Iran J Kidney Dis"},{"key":"4693_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/ki.1981.213","volume":"20","author":"E McSherry","year":"1981","unstructured":"McSherry E (1981) Renal tubular acidosis in childhood. Kidney Int 20:799\u2013809","journal-title":"Kidney Int"},{"key":"4693_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00296-014-2993-3","volume":"34","author":"T Both","year":"2014","unstructured":"Both T, Zietse R, Hoorn EJ et al (2014) Everything you need to know about distal renal tubular acidosis in autoimmune disease. Rheumatol Int 34:1037\u20131045","journal-title":"Rheumatol Int"},{"key":"4693_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1542\/pir.22-8-277","volume":"22","author":"JC Chan","year":"2001","unstructured":"Chan JC, Scheinman JI, Roth KS (2001) Consultation with the specialist: renal tubular acidosis. Pediatr Rev 22:277\u2013287","journal-title":"Pediatr Rev"},{"key":"4693_CR18","doi-asserted-by":"publisher","unstructured":"Guittet C, Roussel-Maupetit C, Manso MA, et al. (2020) Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults. Sci Rep 10:13960. https:\/\/doi.org\/10.1038\/s41598-020-70549-2","DOI":"10.1038\/s41598-020-70549-2"},{"key":"4693_CR19","first-page":"13","volume":"59","author":"J Frey","year":"2001","unstructured":"Frey J, Daudon M, Raby N et al (2001) Valeur s\u00e9miologique des param\u00e8tres biochimiques urinaires. Ann Biol Clin 59:13\u201325","journal-title":"Ann Biol Clin"},{"key":"4693_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0022-3476(97)70162-8","volume":"131","author":"V Matos","year":"1997","unstructured":"Matos V, van Melle G, Boulat O et al (1997) Urinary phosphate\/creatinine, calcium\/creatinine, and magnesium\/creatinine ratios in a healthy pediatric population. J Pediatr 131:252\u2013257","journal-title":"J Pediatr"},{"key":"4693_CR21","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00467-014-2806-7","volume":"29","author":"JK Kirejczyk","year":"2014","unstructured":"Kirejczyk JK, Porowski T, Konstantynowicz J et al (2014) Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol 29:1575\u20131582","journal-title":"Pediatr Nephrol"},{"key":"4693_CR22","first-page":"1051","volume":"9","author":"X Parent","year":"1999","unstructured":"Parent X, Boess G, Brignon P (1999) Lithiase oxalocalcique. Relation entre facteurs de risque biochimiques et phase cristalline du calcul. Prog Urol 9:1051\u20131056","journal-title":"Prog Urol"},{"key":"4693_CR23","unstructured":"EMA (2000) Points to consider on switching between superiority and non-inferiority (CPMP\/EWP\/482\/99)"},{"key":"4693_CR24","unstructured":"FDA (2016) Non-inferiority clinical trials to establish effectiveness. Guidance for industry"},{"key":"4693_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2169\/internalmedicine.54.9421","volume":"54","author":"C Zhang","year":"2015","unstructured":"Zhang C, Ren H, Shen P et al (2015) Clinical evaluation of Chinese patients with primary distal renal tubular acidosis. Intern Med 54:725\u2013730","journal-title":"Intern Med"},{"key":"4693_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.semnephrol.2006.12.001","volume":"26","author":"D Batlle","year":"2006","unstructured":"Batlle D, Moorthi KM, Schlueter W et al (2006) Distal renal tubular acidosis and the potassium enigma. Semin Nephrol 26:471\u2013478","journal-title":"Semin Nephrol"},{"key":"4693_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13256-019-2056-1","volume":"13","author":"G Vasquez-Rios","year":"2019","unstructured":"Vasquez-Rios G, Westrich DJ Jr, Philip I et al (2019) Distal renal tubular acidosis and severe hypokalemia: a case report and review of the literature. J Med Case Rep 13:103\u2013109","journal-title":"J Med Case Rep"},{"key":"4693_CR28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1172\/JCI106537","volume":"50","author":"A Sebastian","year":"1971","unstructured":"Sebastian A, McSherry E, Morris RC Jr (1971) Renal potassium wasting in renal tubular acidosis (RTA): its occurrence in types 1 and 2 RTA despite sustained correction of systemic acidosis. J Clin Invest 50:667\u2013678","journal-title":"J Clin Invest"},{"key":"4693_CR29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0022-5347(17)42374-3","volume":"139","author":"GM Preminger","year":"1988","unstructured":"Preminger GM, Sakhaee K, Pak CY (1988) Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate. J Urol 139:240\u2013242","journal-title":"J Urol"},{"key":"4693_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1464-410X.2012.11292.x","volume":"111","author":"MA Arrabal-Polo","year":"2013","unstructured":"Arrabal-Polo MA, Arrabal-Martin M, Arias-Santiago S et al (2013) Importance of citrate and the calcium:citrate ratio in patients with calcium renal lithiasis and severe lithogenesis. BJU Int 111:622\u2013627","journal-title":"BJU Int"},{"key":"4693_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12894-018-0430-8","volume":"18","author":"A Rodriguez","year":"2018","unstructured":"Rodriguez A, Saez-Torres C, Mir C et al (2018) Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children. BMC Urol 18:116","journal-title":"BMC Urol"}],"updated-by":[{"DOI":"10.1007\/s00467-020-04776-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000}}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04693-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04693-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04693-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T23:16:29Z","timestamp":1627254989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04693-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,26]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4693"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04693-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00467-020-04776-0","asserted-by":"object"}]},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,26]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The published version of the article unfortunately contained a mistake.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"C. Guittet, M.A. Manso-Silv\u00e1n, and L.A. Granier are employees of Advicenne and hold stock options or shares in the company. A. Castang is also an employee of Advicenne. C. Stylianou was paid (contract research) for his contribution to statistical analyses. A. Bertholet perceived support from Advicenne for traveling to meetings and\/or funding for lectures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by regional independent ethics committees and national regulatory health authorities, and conducted in accordance with Good Clinical Practice and the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all adult patients, and from the parents or legal guardians of all children. When possible, the assent from pediatric patients themselves was also obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}